Skip to main content
A

AUSTRALIAN CLINICAL LABS LIMITED — Investor Relations & Filings

Ticker · ACL ISIN · AU0000148496 ASX Human health and social work activities
Open in API
Filings indexed 623 across all filing types
Latest filing 2026-04-26 Regulatory Filings
Country AU Australia
Listing ASX ACL

About AUSTRALIAN CLINICAL LABS LIMITED

https://www.clinicallabs.com.au/

Australian Clinical Labs Limited is a provider of diagnostic pathology services. The company operates a network of accredited laboratories and collection centers, offering a comprehensive range of pathology tests. These services include routine clinical testing such as biochemistry, hematology, and microbiology, as well as specialized diagnostics in areas like histopathology, cytology, molecular pathology, and genetics. The organization serves a diverse client base, including general practitioners, medical specialists, private hospitals, and corporate entities. By leveraging advanced diagnostic technologies and integrated digital health platforms, the company focuses on delivering accurate and timely clinical results to support patient management and public health outcomes. Its operations span multiple regions, providing critical diagnostic infrastructure to support clinical decision-making.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder from MQG 34 pages 234.4KB
Regulatory Filings
2026-04-26 English
Notification of cessation of securities - ACL 4 pages 14.8KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3H form titled “Notification of cessation of securities” detailing an on-market buy-back where the company cancelled 232,345 ordinary shares. This is a report of the company buying back (and cancelling) its own shares. It matches the “Transaction in Own Shares” category (POS).
2026-04-22 English
Change in substantial holding 8 pages 337.0KB
Major Shareholding Notification Classification · 1% confidence The document is a Form 604 ‘‘Notice of change of interests of substantial holder’’ under the Corporations Act 2001, detailing Pinnacle Investment Management’s movements in shareholding percentages, voting power, annexures of holdings, and associated entities. This is clearly a notification of changes in significant share ownership levels, matching the definition of a Major Shareholding Notification.
2026-04-22 English
Class action proceedings 1 page 187.5KB
Legal Proceedings Report Classification · 1% confidence The document is an ASX announcement detailing that Australian Clinical Labs Limited has been served with a class action lawsuit in the Supreme Court of Victoria. It outlines the nature of the legal claim, denies the allegations, and states intent to defend. This is a clear update on significant legal proceedings involving the company, matching the definition of a Legal Proceedings Report (Code: LTR).
2026-04-20 English
Update - Notification of buy-back - ACL 6 pages 18.5KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C “Notification of buy-back” detailing daily on-market share repurchases by Australian Clinical Labs including volumes, dates, prices and buy-back limits. This is a report of the company purchasing its own shares, matching the “Transaction in Own Shares” category (Code: POS).
2026-04-16 English
Ceasing to be a substantial holder 3 pages 261.2KB
Major Shareholding Notification Classification · 1% confidence The document is an Australian Form 605 "Notice of ceasing to be a substantial holder" under the Corporations Act. It details changes in relevant interests, acquisition and disposal of shares by United Super Pty Ltd, and reports the cessation of substantial holding. This is a statutory major shareholding notification, matching the "Major Shareholding Notification" category.
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.